Microbiota in Gastric Cancer by Gastric Mucosal Brushing - Trial NCT06325891
Access comprehensive clinical trial information for NCT06325891 through Pure Global AI's free database. This phase not specified trial is sponsored by King Chulalongkorn Memorial Hospital and is currently Recruiting. The study focuses on Gastric Cancer. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
King Chulalongkorn Memorial Hospital
Timeline & Enrollment
N/A
Feb 01, 2024
May 31, 2025
Primary Outcome
Microbiome analysis using gastric mucosal brushing
Summary
Many studies have shown a significant change of diversity and composition in gut microbiota
 across the gastric carcinogenesis process, particularly in patients with gastric cancer.
 However, there has been no analysis of gastric microbiota using the mucosal brushing
 technique, despite its favoring benefit in microbiota study. Therefore, this study aims to
 evaluate microbiota profile in patients with gastric cancer, compared to those without
 gastric cancer by using mucosal brush sampling. This will improve current knowledge of the
 potential role of the microbiome in patient gastric cancer as a future biomarker marker using
 brushing sampling.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06325891
Non-Device Trial